These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 20699442

  • 1. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS, Sun DS, Lien TS, Chang HH.
    Blood; 2010 Dec 02; 116(23):5002-9. PubMed ID: 20699442
    [Abstract] [Full Text] [Related]

  • 2. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
    Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH.
    Nat Med; 2006 Jun 02; 12(6):688-92. PubMed ID: 16715090
    [Abstract] [Full Text] [Related]

  • 3. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
    Crow AR, Song S, Semple JW, Freedman J, Lazarus AH.
    Blood; 2007 Jan 01; 109(1):155-8. PubMed ID: 16954498
    [Abstract] [Full Text] [Related]

  • 4. Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.
    Leontyev D, Katsman Y, Branch DR.
    Blood; 2012 May 31; 119(22):5261-4. PubMed ID: 22508937
    [Abstract] [Full Text] [Related]

  • 5. Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia.
    Kapur R, Aslam R, Kim M, Guo L, Ni H, Segel GB, Semple JW.
    Platelets; 2017 Jul 31; 28(5):521-524. PubMed ID: 27885866
    [Abstract] [Full Text] [Related]

  • 6. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH.
    J Clin Immunol; 2010 May 31; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [Abstract] [Full Text] [Related]

  • 7. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
    Schwab I, Biburger M, Krönke G, Schett G, Nimmerjahn F.
    Eur J Immunol; 2012 Apr 31; 42(4):826-30. PubMed ID: 22278120
    [Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition.
    Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH.
    Blood; 2021 Apr 15; 137(15):2114-2124. PubMed ID: 33662988
    [Abstract] [Full Text] [Related]

  • 9. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
    Leontyev D, Katsman Y, Ma XZ, Miescher S, Käsermann F, Branch DR.
    Transfusion; 2012 Aug 15; 52(8):1799-805. PubMed ID: 22257295
    [Abstract] [Full Text] [Related]

  • 10. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
    Lewis BJB, Leontyev D, Neschadim A, Blacquiere M, Branch DR.
    Clin Exp Immunol; 2018 Sep 15; 193(3):293-301. PubMed ID: 29704458
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
    Song S, Crow AR, Siragam V, Freedman J, Lazarus AH.
    Blood; 2005 Feb 15; 105(4):1546-8. PubMed ID: 15479722
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.
    Teeling JL, Jansen-Hendriks T, Kuijpers TW, de Haas M, van de Winkel JG, Hack CE, Bleeker WK.
    Blood; 2001 Aug 15; 98(4):1095-9. PubMed ID: 11493456
    [Abstract] [Full Text] [Related]

  • 13. Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.
    Sehgal K, Guo X, Koduru S, Shah A, Lin A, Yan X, Dhodapkar KM.
    Sci Transl Med; 2013 Jul 10; 5(193):193ra89. PubMed ID: 23843450
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.
    Hansen RJ, Balthasar JP.
    J Pharm Sci; 2003 Jun 10; 92(6):1206-15. PubMed ID: 12761810
    [Abstract] [Full Text] [Related]

  • 15. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
    Crow AR, Lazarus AH.
    Semin Hematol; 2016 Apr 10; 53 Suppl 1():S20-2. PubMed ID: 27312158
    [Abstract] [Full Text] [Related]

  • 16. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
    Crow AR, Amash A, Lazarus AH.
    Transfusion; 2015 Jun 10; 55(6 Pt 2):1492-500. PubMed ID: 25496771
    [Abstract] [Full Text] [Related]

  • 17. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR, Lazarus AH.
    Transfus Med Rev; 2008 Apr 10; 22(2):103-16. PubMed ID: 18353251
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ, Balthasar JP.
    Clin Lab; 2004 Apr 10; 50(3-4):133-40. PubMed ID: 15074465
    [Abstract] [Full Text] [Related]

  • 19. Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.
    Hansen RJ, Balthasar JP.
    Thromb Haemost; 2002 Dec 10; 88(6):898-9. PubMed ID: 12529736
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S, Crow AR, Freedman J, Lazarus AH.
    Blood; 2003 May 01; 101(9):3708-13. PubMed ID: 12506021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.